Skip to main content

Table 3 Intra-Aortic Balloon Pump and Antithrombotic Characteristics

From: Comparison of anticoagulated versus non-anticoagulated patients with intra-aortic balloon pumps

  Heparin group (n = 82) Non-heparin group (n = 65)
Time on IABP (hours)a 42 (30–68) 26 (17–45)
Time in 1:1 Settinga 36 (18.8–62.5) 19 (10–40)
Time in 1:2 Settinga 5 (3–11) 4 (2–14)
Time in 1:3 Settinga 2 (1–3) 1
PTT goal range 60–80 54 (65.9) N/A
PTT goal range 50–70 21 (25.6) N/A
Other PTT goal 7 (8.5) N/A
Rate of heparin (units/kg/hr)a 12 (9–15) N/A
Time on heparin (hours)a 56 (32–89 N/A
Percent of time in therapeutic rangea 44.8 ± 27.8 N/A
Received concomitant aspirin monotherapy 42 (51.2) 42 (64.6)
Received concomitant dual antiplatelet therapyc 22 (26.8) 9 (13.8)
Received concomitant dual antiplatelet therapy with clopidogrel and aspirin 14 (17.1) 9 (13.8)
Received concomitant dual antiplatelet therapy with ticagrelor and aspirin 8 (9.8) 0
  1. All values are n(%) unless otherwise specified
  2. PTT partial thromboplastin time
  3. amean +/−SD
  4. bmedian (IQR)
  5. cDual antiplatelet therapy is defined as being on both aspirin and a P2Y12 inhibitor